Skip to main content

7 Result(s)

within Kou-Rong Miao Remove this filter

and

  1. No Access

    Article

    Haploidentical hematopoietic stem cell transplantation following myeloablative conditioning regimens in hematologic diseases with G-CSF-mobilized peripheral blood stem cells grafts without T cell depletion: a single center report of 38 cases

    Many Chinese patients with hematologic diseases, who need allogeneic hematopoietic stem cell transplantation (HSCT), lack a human leukocyte antigen-matched donor. To save these patients and to avoid collectin...

    Rui-Nan Lu, Kou-Rong Miao, Run Zhang, Ming Hong, Ji Xu, Yu Zhu… in Medical Oncology (2014)

  2. No Access

    Article

    High-dose idarubicin plus busulfan as conditioning regimen to autologous stem cell transplantation: Promising post-remission therapy for acute myeloid leukemia in first complete remission?

    The optimal post-remission therapy (PRT) for acute myeloid leukemia (AML) remains uncertain. We reported 32 AML patients in first complete remission (CR1) undergoing autologous hematopoietic stem cell transpla...

    Ming Hong, Kou-Rong Miao, Run Zhang, Hua Lu, Peng Liu, Wei Xu… in Medical Oncology (2014)

  3. No Access

    Article

    Comprehensive assessment of prognostic factors predicting outcome in Chinese patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide

    To determine whether prognostic factors remain relevant to chronic lymphocytic leukemia (CLL) patients treated with fludarabine and cyclophosphamide (FC), we prospectively evaluated 86 Chinese CLL patients who...

    Min Xu, Lei Fan, Kou-Rong Miao, Peng Liu, Wei Xu, Jian-Yong Li in Medical Oncology (2012)

  4. No Access

    Article

    Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma

    MicroRNAs (miRNAs) are regulatory RNA molecules that are deregulated in many disease types, including cancer. Recently, miRNAs have shown promise as markers for cancer diagnosis. The aim of this study was to i...

    Cheng Fang, Dan-**a Zhu, Hua-Jie Dong, Zhi-Jian Zhou, Yin-Hua Wang… in Annals of Hematology (2012)

  5. No Access

    Article

    The prognostic significance of TP53 mutations in Chinese patients with chronic lymphocytic leukemia is independent of del(17p13)

    The poor prognosis of chronic lymphocytic leukemia (CLL) patients with del(17p13) is well established. Several studies have shown that cases with TP53 mutations and TP53 mutations without del(17p13) may be adv...

    Hua-Jie Dong, Li-Tao Zhou, Dan-**a Zhu, Dong-Mei Wang, Cheng Fang… in Annals of Hematology (2011)

  6. No Access

    Article

    Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia

    The human multidrug resistance gene (MDR1, ABCB1) codes for P-glycoprotein (P-gp) that affects the pharmacokinetics of many drugs. MDR1 single nucleotide polymorphisms (SNPs) are associated with drug clearance. I...

    Ling-Na Ni, Jian-Yong Li, Kou-Rong Miao, Chun Qiao, Su-Jiang Zhang… in Medical Oncology (2011)

  7. No Access

    Article

    Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors

    Chronic lymphocytic leukemia (CLL) shows a remarkable heterogeneity, with some patients having an almost normal lifespan, others surviving only several months after diagnosis despite intensive therapy. The aim...

    Wei Xu, **n Cao, Kou-Rong Miao, Chun Qiao, Yu-Jie Wu… in International Journal of Hematology (2009)